Brugia
A parasitic worm causing lymphatic filariasis
Brugia is a genus of parasitic nematodes that are responsible for causing lymphatic filariasis in humans. The most notable species within this genus are Brugia malayi and Brugia timori. These parasites are transmitted to humans through the bites of infected mosquitoes.
Life Cycle[edit | edit source]
The life cycle of Brugia species involves both a human host and a mosquito vector. The adult worms reside in the lymphatic system of the human host, where they can cause significant damage and lead to the symptoms associated with lymphatic filariasis.
Mosquito Vector[edit | edit source]
The life cycle begins when a mosquito takes a blood meal from an infected human, ingesting microfilariae, which are the larval stage of the parasite. Inside the mosquito, the microfilariae develop into infective larvae over a period of 10-14 days.
Human Host[edit | edit source]
When the mosquito bites another human, the infective larvae are transmitted into the skin. The larvae then migrate to the lymphatic vessels, where they mature into adult worms. The adult worms can live for several years, producing millions of microfilariae that circulate in the blood.
Pathogenesis[edit | edit source]
The presence of adult worms in the lymphatic system can lead to a range of symptoms, including lymphedema, elephantiasis, and hydrocele. The severity of the disease is often related to the number of worms present and the duration of the infection.
Diagnosis[edit | edit source]
Diagnosis of Brugia infection is typically made by identifying microfilariae in a blood sample. Blood samples are usually collected at night, when the microfilariae are most active in the peripheral blood.
Treatment[edit | edit source]
Treatment of lymphatic filariasis caused by Brugia species involves the use of antiparasitic medications such as diethylcarbamazine (DEC) and ivermectin. These medications help to reduce the number of microfilariae in the blood and alleviate symptoms.
Prevention[edit | edit source]
Preventive measures include controlling mosquito populations and avoiding mosquito bites through the use of insect repellent, bed nets, and wearing protective clothing. Mass drug administration programs are also implemented in endemic areas to reduce the prevalence of the disease.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD